NYSEArca - Delayed Quote USD

ProShares Nanotechnology ETF (TINY)

44.65 -1.45 (-3.14%)
At close: April 19 at 11:46 AM EDT
Loading Chart for TINY
DELL
  • Previous Close 46.09
  • Open 45.60
  • Bid 42.00 x 900
  • Ask 49.53 x 1200
  • Day's Range 44.65 - 45.19
  • 52 Week Range 31.47 - 51.89
  • Volume 927
  • Avg. Volume 2,061
  • Net Assets 4.97M
  • NAV 46.18
  • PE Ratio (TTM) --
  • Yield 0.26%
  • YTD Daily Total Return 10.44%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.58%

The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. The adviser seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction. The fund is non-diversified.

ProShares

Fund Family

Technology

Fund Category

4.97M

Net Assets

2021-10-26

Inception Date

Performance Overview: TINY

Trailing returns as of 4/18/2024. Category is Technology.

YTD Return

TINY
10.44%
Category
8.66%
 

1-Year Return

TINY
39.44%
Category
31.83%
 

3-Year Return

TINY
0.00%
Category
3.17%
 

People Also Watch

Holdings: TINY

Top 10 Holdings (52.24% of Total Assets)

SymbolCompany% Assets
7735.T
SCREEN Holdings Co., Ltd. 7.90%
NVDA
NVIDIA Corporation 6.57%
LRCX
Lam Research Corporation 4.90%
ASML.AS
ASML Holding N.V. 4.81%
BRKR
Bruker Corporation 4.81%
6728.T
ULVAC, Inc. 4.76%
ENTG
Entegris, Inc. 4.72%
ONTO
Onto Innovation Inc. 4.66%
AMAT
Applied Materials, Inc. 4.61%
KLAC
KLA Corporation 4.49%

Sector Weightings

SectorTINY
Technology   78.97%
Healthcare   9.67%
Industrials   4.78%
Real Estate   0.00%
Utilities   0.00%
Energy   0.00%

Related ETF News

Research Reports: TINY

  • Daily – Vickers Top Buyers & Sellers for 04/19/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • ARWR: Lowering target price to $25.00

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $25.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Neutral
    Price Target
     
  • ARWR: What does Argus have to say about ARWR?

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Neutral
    Price Target
     
  • ARWR: Raising target price to $31.00

    ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $31.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Neutral
    Price Target
     

Related Tickers